Loading…
AI investor
A data-grounded assistant: it reads a company’s fundamentals, valuation and earnings and lays out the bull and bear case.
Screens well
Eli Lilly and Company is growing revenue +48% a year at a +34% net margin, and trades on 24.3× forward earnings. Analysts rate it “buy” and it generates $11.07B of free cash flow. Overall it screens as a quality business at a reasonable price.